WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it will be participating at upcoming conferences.
- H.C. Wainwright 25th Annual Global Investment Conference – Monday, September 11, 2023 at 8:30 am (ET)
- Morgan Stanley 21st Annual Global Healthcare Conference – Wednesday, September 13, 2023 at 8:10 am (ET)
- 2023 Cantor Global Healthcare Conference – Wednesday, September 27, 2023 at 11:30 ...